

BioMarin develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions. Among its major competitors, BioMarin Pharmaceutical is ranked in 7th place for NPS while Genentech is 1st, and Sanofi is 2nd.Their current market cap is $14.84B